Conjunctiva-associated lymphoid tissue (CALT) and local immunoregulatory mediators (e.g., TGF-β2, Fas-ligand) may amplify the immune-modulatory effects of ultra-low doses [34]. Here, TGFB2 is linked to eye adnexa disorder.